Citadel Advisors
IGMS

Citadel Advisors’s IGM Biosciences IGMS Stock Holding History

Citadel Advisors’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-800
Closed -$920 – 13692
2025
Q1 		$920 Sell
800
-5,200
-87% -$9.67K ﹤0.01% 14195
2024
Q4 		$36.7K Buy
6,000
+800
+15% +$9.51K ﹤0.01% 12688
2024
Q3 		$86K Buy
5,200
+1,300
+33% +$14.2K ﹤0.01% 11316
2024
Q2 		$26.8K Sell
3,900
-1,200
-24% -$10.3K ﹤0.01% 12380
2024
Q1 		$49.2K Buy
5,100
+1,400
+38% +$16.2K ﹤0.01% 12184
2023
Q4 		$30.7K Buy
3,700
+2,600
+236% +$15.1K ﹤0.01% 12248
2023
Q3 		$9.19K Sell
1,100
-800
-42% -$6.79K ﹤0.01% 13145
2023
Q2 		$17.5K Sell
1,900
-4,100
-68% -$45.9K ﹤0.01% 12843
2023
Q1 		$82.4K Sell
6,000
-3,500
-37% -$72.4K ﹤0.01% 11517
2022
Q4 		$162K Sell
9,500
-19,100
-67% -$382K ﹤0.01% 10493
2022
Q3 		$650K Buy
28,600
+14,600
+104% +$295K ﹤0.01% 7898
2022
Q2 		$252K Sell
14,000
-71,200
-84% -$1.27M ﹤0.01% 10205
2022
Q1 		$2.28M Buy
+85,200
New +$1.59M ﹤0.01% 5799
2021
Q4 		– Sell
-4,200
Closed -$276K – 14239
2021
Q3 		$276K Sell
4,200
-2,200
-34% -$168K ﹤0.01% 11231
2021
Q2 		$532K Sell
6,400
-15,800
-71% -$1.17M ﹤0.01% 9927
2021
Q1 		$1.7M Sell
22,200
-17,700
-44% -$1.61M ﹤0.01% 6786
2020
Q4 		$3.52M Buy
39,900
+33,100
+487% +$2.33M ﹤0.01% 4307
2020
Q3 		$502K Buy
+6,800
New +$403K ﹤0.01% 7299

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors's IGMS Position: Q3 2024 in Review

Citadel Advisors sold out of IGM Biosciences (IGMS) in Q3 2024, closing a stake of 1,979 shares — an estimated $21.7K sold.

Citadel Advisors first reported a position in IGMS in Q3 2019 and held it in 18 quarters. The position peaked at $3.78M in Q4 2020. 72 funds tracked by Wall St. Rank hold IGMS as of Q3 2024.

  • Citadel Advisors reported no remaining IGM Biosciences position as of Q3 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,979 IGM Biosciences shares in Q3 2024, an estimated $21.7K.
  • Citadel Advisors first reported a position in IGM Biosciences in Q3 2019 and held it in 18 quarters.
  • Citadel Advisors's IGM Biosciences position peaked at $3.78M in Q4 2020.
  • 72 funds tracked by Wall St. Rank held IGM Biosciences as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.